Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Schoepfer

Showing results (61-70 of 126) with videos related to

Pageof 13
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 1, 2011
Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitisAlex Straumann, Sebastien Conus, Lukas Degen, et al.
Alimentary Pharmacology & Therapeutics|April 28, 2020
Editorial: fluticasone propionate orally disintegrating tablets-interesting concept but is it going anywhere? Authors' replyIkuo Hirano, Ekaterina Safroneeva, Marie C Roumet, et al.
Surgical Oncology|January 14, 2023
Preoperative hiatal hernia in esophageal adenocarcinoma; does it have an impact on patient outcomes?Pénélope St-Amour, Styliani Mantziari, Clarisse Dromain, et al.
Scandinavian Journal of Gastroenterology|April 30, 2015
Characteristics of non-responders to self-reported questionnaires in a large inflammatory bowel disease cohort studyEléonore Multone, John-Paul Vader, Christian Mottet, et al.
Alimentary Pharmacology & Therapeutics|March 10, 2020
Randomised clinical trial: the safety and tolerability of fluticasone propionate orally disintegrating tablets versus placebo for eosinophilic oesophagitisIkuo Hirano, Ekaterina Safroneeva, Marie C Roumet, et al.
Zeitschrift Fur Gastroenterologie|August 14, 2018
[Ustekinumab - Current position]Britta Siegmund, Christoph Högenauer, Gottfried Novacek, et al.
Scandinavian Journal of Gastroenterology|May 24, 2016
Prevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease CohortAdriano Alatri, Alain Schoepfer, Nicolas Fournier, et al.
Digestion|May 29, 2013
Penetrating or stricturing diseases are the major determinants of time to first and repeat resection surgery in Crohn's diseaseValerie Pittet, Gerhard Rogler, Pierre Michetti, et al.
Inflammatory Intestinal Diseases|June 3, 2026
Impact of Paediatric-Onset Inflammatory Bowel Disease on Educational Paths and CareersCléa Kunz, Alain Schoepfer, Jean-Benoît Rossel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 19, 2021
Sex Impacts Disease Activity But Not Symptoms or Quality of Life in Adults With Eosinophilic EsophagitisPhilipp Schreiner, Ekaterina Safroneeva, Jean-Benoit Rossel, et al.
Pageof 13

Showing results (61-70 of 126) with videos related to

Sort By:
Pageof 13
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 1, 2011
Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitisAlex Straumann, Sebastien Conus, Lukas Degen, et al.
Alimentary Pharmacology & Therapeutics|April 28, 2020
Editorial: fluticasone propionate orally disintegrating tablets-interesting concept but is it going anywhere? Authors' replyIkuo Hirano, Ekaterina Safroneeva, Marie C Roumet, et al.
Surgical Oncology|January 14, 2023
Preoperative hiatal hernia in esophageal adenocarcinoma; does it have an impact on patient outcomes?Pénélope St-Amour, Styliani Mantziari, Clarisse Dromain, et al.
Scandinavian Journal of Gastroenterology|April 30, 2015
Characteristics of non-responders to self-reported questionnaires in a large inflammatory bowel disease cohort studyEléonore Multone, John-Paul Vader, Christian Mottet, et al.
Alimentary Pharmacology & Therapeutics|March 10, 2020
Randomised clinical trial: the safety and tolerability of fluticasone propionate orally disintegrating tablets versus placebo for eosinophilic oesophagitisIkuo Hirano, Ekaterina Safroneeva, Marie C Roumet, et al.
Zeitschrift Fur Gastroenterologie|August 14, 2018
[Ustekinumab - Current position]Britta Siegmund, Christoph Högenauer, Gottfried Novacek, et al.
Scandinavian Journal of Gastroenterology|May 24, 2016
Prevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease CohortAdriano Alatri, Alain Schoepfer, Nicolas Fournier, et al.
Digestion|May 29, 2013
Penetrating or stricturing diseases are the major determinants of time to first and repeat resection surgery in Crohn's diseaseValerie Pittet, Gerhard Rogler, Pierre Michetti, et al.
Inflammatory Intestinal Diseases|June 3, 2026
Impact of Paediatric-Onset Inflammatory Bowel Disease on Educational Paths and CareersCléa Kunz, Alain Schoepfer, Jean-Benoît Rossel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 19, 2021
Sex Impacts Disease Activity But Not Symptoms or Quality of Life in Adults With Eosinophilic EsophagitisPhilipp Schreiner, Ekaterina Safroneeva, Jean-Benoit Rossel, et al.
Pageof 13